GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » 14-Day RSI

Lionco Pharmaceutical Group Co (SHSE:603669) 14-Day RSI : 75.32 (As of Dec. 13, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-13), Lionco Pharmaceutical Group Co's 14-Day RSI is 75.32.

The industry rank for Lionco Pharmaceutical Group Co's 14-Day RSI or its related term are showing as below:

SHSE:603669's 14-Day RSI is ranked worse than
97.08% of 1095 companies
in the Drug Manufacturers industry
Industry Median: 49.56 vs SHSE:603669: 75.32

Competitive Comparison of Lionco Pharmaceutical Group Co's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Lionco Pharmaceutical Group Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lionco Pharmaceutical Group Co's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lionco Pharmaceutical Group Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Lionco Pharmaceutical Group Co's 14-Day RSI falls into.



Lionco Pharmaceutical Group Co  (SHSE:603669) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lionco Pharmaceutical Group Co  (SHSE:603669) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Lionco Pharmaceutical Group Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Lionco Pharmaceutical Group Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Lionco Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
68 Zetang Nedong commercial building, 2nd Floor, Shannan Prefecture, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Executives
Zhang Jun Ke Director
Wang Wen Nan Director
Tao Xiao Gang Director
Tao Ling Gang Director
Tao Ling Ping Director

Lionco Pharmaceutical Group Co Headlines

No Headlines